Nikola Corporation has filed Prospectus Supplement No. 96 to update and supplement information in its previous prospectus dated July 17, 2020. This filing is associated with the issuance of up to 53,390,000 shares of common stock and up to 23,890,000 shares issuable upon the exercise of warrants. The supplement, dated August 19, 2024, includes details from a current report filed with the SEC on the same date. The shares in question include those issuable upon the exercise of both private and public warrants originally issued during VectoIQ's initial public offering. Additionally, the supplement covers the potential sale of these shares by selling securityholders. Nikola's common stock is traded on the Nasdaq Global Select Market under the symbol 'NKLA', with a closing price of $8.13 as of...Show More

Nikola Corporation has filed Prospectus Supplement No. 96 to update and supplement information in its previous prospectus dated July 17, 2020. This filing is associated with the issuance of up to 53,390,000 shares of common stock and up to 23,890,000 shares issuable upon the exercise of warrants. The supplement, dated August 19, 2024, includes details from a current report filed with the SEC on the same date. The shares in question include those issuable upon the exercise of both private and public warrants originally issued during VectoIQ's initial public offering. Additionally, the supplement covers the potential sale of these shares by selling securityholders. Nikola's common stock is traded on the Nasdaq Global Select Market under the symbol 'NKLA', with a closing price of $8.13 as of August 16, 2024. The supplement emphasizes that it must be read in conjunction with the original prospectus and that the information contained within supersedes any conflicting information from the earlier document. The SEC has not approved or disapproved the securities nor confirmed the completeness or accuracy of the prospectus supplement or the original prospectus.